Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/32830
Full metadata record
DC FieldValueLanguage
dc.contributor.authorUeda, Peter
dc.contributor.authorWoodward, Mark
dc.contributor.authorLu, Yuan
dc.contributor.authorHajifathalian, Kaveh
dc.contributor.authorAl-Wotayan, Rihab
dc.contributor.authorAguilar-Salinas, Carlos A
dc.contributor.authorAhmadvand, Alireza
dc.contributor.authorAzizi, Fereidoun
dc.contributor.authorBentham, James
dc.contributor.authorCifkova, Renata
dc.contributor.authorDi Cesare, Mariachiara
dc.contributor.authorEriksen, Louise
dc.contributor.authorFarzadfar, Farshad
dc.contributor.authorFerguson, Trevor S
dc.contributor.authorIkeda, Nayu
dc.contributor.authorKhalili, Davood
dc.contributor.authorKhang, Young-Ho
dc.contributor.authorLanska, Vera
dc.contributor.authorLeón-Muñoz, Luz
dc.contributor.authorMagliano, Dianna J
dc.contributor.authorMargozzini, Paula
dc.contributor.authorMsyamboza, Kelias P
dc.contributor.authorMutungi, Gerald
dc.contributor.authorOh, Kyungwon
dc.contributor.authorOum, Sophal
dc.contributor.authorRodríguez-Artalejo, Fernando
dc.contributor.authorRojas-Martinez, Rosalba
dc.contributor.authorValdivia, Gonzalo
dc.contributor.authorWilks, Rainford
dc.contributor.authorShaw, Jonathan E
dc.contributor.authorStevens, Gretchen A
dc.contributor.authorTolstrup, Janne S
dc.contributor.authorZhou, Bin
dc.contributor.authorSalomon, Joshua A
dc.contributor.authorEzzati, Majid
dc.contributor.authorDanaei, Goodarz
dc.date.accessioned2019-06-28T17:08:53Z-
dc.date.available2019-06-28T17:08:53Z-
dc.date.issued2017
dc.identifier.citationLancet Diabetes Endocrinol.2017 03;(5)3:196-213
dc.identifier.urihttps://hdl.handle.net/20.500.12530/32830-
dc.description.abstractWorldwide implementation of risk-based cardiovascular disease (CVD) prevention requires risk prediction tools that are contemporarily recalibrated for the target country and can be used where laboratory measurements are unavailable. We present two cardiovascular risk scores, with and without laboratory-based measurements, and the corresponding risk charts for 182 countries to predict 10-year risk of fatal and non-fatal CVD in adults aged 40-74 years.
dc.language.isoeng
dc.rightsopenAccess-
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshCardiovascular Diseases
dc.subject.meshFemale
dc.subject.meshGlobal Health
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshProspective Studies
dc.subject.meshRisk Assessment
dc.subject.meshRisk Factors
dc.titleLaboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys.
dc.typeArtículo
dc.identifier.pubmedID28126460
dc.format.volume5
dc.format.page196-213
dc.identifier.e-issn2213-8595
dc.identifier.journalThe lancet. Diabetes & endocrinology
dc.identifier.doi10.1016/S2213-8587(17)30015-3
dc.format.number3
dc.identifier.pmcPMC5354360
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, N.I.H., Extramural
dc.pubmedtypeResearch Support, Non-U.S. Gov't
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos

Files in This Item:
File Description SizeFormat 
PMC5354360.pdf7.21 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.